CD8A and neoplasm: In the TME, CD8+ T cells constitute the major immune cell population; they interact with the peptide-major histocompatibility complex class I (MHC-I) molecules on antigen-presenting cells (APCs), differentiate to cytotoxic T lymphcytes (CTLs), and exhibit cytotoxicity against tumor cells (Iwahori 2020).